Jimmy J. Caudell MD, PhD

Dr. Caudell joined the Moffitt Faculty in October 2011 as Assistant Member in the Head and Neck Program, Radiation Oncology specializing in the treatment of head and neck cancers. Dr. Caudell’s clinical interests include treatment of head and neck cancer and cutaneous malignancies with radioth­­­erapy. Research interests include prediction of radiation sensitivity, evaluation of novel radiosensitizers and radioprotectants, as well as the use of technology to improve radiation delivery for head and neck cancer.

Dr. Caudell is currently co-PI on the national NRG HN-002 prospective clinical trial testing methods to reduce toxicity for patients with low-risk oropharyngeal HPV positive H&N cancer. In addition, Dr. Caudell is PI on a phase I dose-escalation trial of H&N SBRT with concurrent chemotherapy for patients with recurrent, unresectable H&N cancer. He is also PI of a grant to predict the benefit of postoperative radiotherapy in H&N cancer using a gene expression signature of tumor radiosensitivity. Dr. Caudell continues his research through a retrospective analysis of patients treated for H&N malignancies (primary and metastatic).